Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methods

Clinical Chemistry

Volumn 42, Issue 6 SUPPL., 1996, Pages 904-909

  Carpenter, Karen M ^a   Durrant, Lindy G ^b   Morgan, Kevin ^a   Bennett, David ^a   Hardcastle, Jack D ^a   Kalsheker, Noor A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Amplification refractory mutation system; Competitive allele specific oligonucleotide hybridization; Dot blot hybridization; Mutant enriched polymerase chain reaction

Indexed keywords

ARTICLE; COLORECTAL CANCER; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; ONCOGENE K RAS; POLYMERASE CHAIN REACTION;

BASE SEQUENCE; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; GENES, RAS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; VALINE;

TRIXIS;

EID: 0029951969     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.6.904     Document Type: Article

References (25)

1. Bos JL. ras oncogenes in human cancer. Cancer Res 1989;49: 4682-9.
2. Laurent-Puig P, Olschwang S, Delattre O, Validre P, Melot T, Mosseri V, et al. Association of Ki-ras mutation with differentiation and tumor formation pathways in colorectal carcinoma. Int J Cancer 1991;49:220-3.
3. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinomas. Gastroenterology 1990;99:416-20.
4. Bell SM, Kelly SA, Hoyle JA, Lewis FA, Taylor GR, Thompson H, et al. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 1991;64:174-8.
5. Shaw P, Tardy S, Benito E, Obrador A, Costa J. Occurance of Ki-ras and p53 mutations in primary colorectal tumours. Oncogene 1991;6:2121-8.
6. Verlaan-de Vries M, Bogaard ME, van den Elst H, van Boom JH, van der Eb AJ, Bos JTA. Dot blot screening procedure for mutated oncogenes using synthetic oligonucleotides. Gene 1986;50:313-20.
7. Jiang W, Kahn SM, Guillem JG, Shihtlsin L, Weinstein BI. Rapid detection of ras oncogenes in human tumours: applications to colon, oesophageal and gastric cancer. Oncogene 1989;4: 923-8.
8. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumourigenesis. Nature 1987;327:298-303.
9. Kahn SM, Jiang W, Culbertson TA, Weinstein BI, Williams GM, Tomita N, Ronai Z. Rapid and sensitive nonradioactive detection of mutant K-ras genes via enriched PCR amplification. Oncogene 1991;6:1079-83.
10. Levi S, Urbano-Ispizua A, Gill R, Thomas DH, Gilbertson J, Foster C, Marshall CJ. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
11. Tobi M, Luo FC, Ronai ZJ. Detection of K-ras mutations in colonic effluent samples from patients without evidence of colorectal carcinoma. J Natl Cancer Inst 1994;86:1007-10.
12. Newton CR, Graham A, Hepstinall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-16.
13. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, Sninsky JJ. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
14. Takeda S, Ichii S, Nakamura Y. Detection of K-ras mutation in sputum by mutant allele specific amplification. Hum Mutat 1993; 2:112-7.
15. Carpenter K, Morgan K, Durrant LG, Hardcastle JD, Kalsheker N. The sensitivity of competitive hybridisation for the detection of mutant p53 alleles in a background of wild type. Biochem Soc Trans 1995;23:129S.
16. 1-antitrypsin deficiency. Clin Chem 1993;39:2157-62.
17. Capon DJ, Seeburg PH, McGrath JP, Hayflick JS, Edman U, Levinson AD, Goeddel DV. Activation of Ki-ras 2 gene in human colon and lung carcinoma by two different point mutations. Nature 1983;304:507.
18. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Volgestein B. Prevalence of ras gene mutations in human colorectal cancer. Nature 1987;327:293-7.
19. Hruban RH, van Mansfield AD, Offerhaus GJ, van Weering DH, Callison DC, Goldman SN, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-53.
20. Minamoto T, Yasashita N, Ochiai A, Mai M, Sugimura T, Ronai Z, Esumi H. Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumor-genesis. Cancer 1995;75:1520-6.
21. Volgestein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
22. Fearon ER, Volgestein BA. Genetic model for colorectal tumor development. Cell 1990;61:759-67.
23. Mills NE, Fishman CL, Rom WN, Dublin N, Jacobson DR. Increased prevalence of K-ras oncogene mutations. Cancer Res 1995;55: 1444-7.
24. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adeno-carcinoma and pancreatic ductal hyperplasia. Cancer Res 1994;54:3568-73.
25. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-7.